US Election is the Biggest Challenge to Healthcare Stocks

The healthcare sector remains robust despite cost pressures ahead of US election says AXA Framlington's healthcare fund manger Dani Saurymper

Karen Kwok 14 April, 2016 | 2:01PM
Facebook Twitter LinkedIn

The US election is the “biggest fundamental driver” of negative sentiment in the healthcare sector, AXA Framlington Health fund manager Dani Saurymper told Morningstar. Candidates of both parties are currently chasing votes by suggesting healthcare reforms, adding a healthcare cost pressure and uncertainty.

The healthcare industry is facing growing cost pressure as the US politicians chased votes by suggesting more price control in drugs and attacking drug price gouging, according to Saurymper.

Drug pricing became a target in the political debates following public outcry over the case of Martin Shkreli and his company Turing Pharmaceuticals, which raised the price of a drug often given to cancer and AIDs patients.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
AXA Framlington Health A Acc229.40 GBP-0.39Rating
DexCom Inc568.34 USD0.00Rating
GlaxoSmithKline PLC1,424.60 GBP0.00Rating

About Author

Karen Kwok

Karen Kwok  is a Reporter for